Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
(NASDAQ: ALLR) Delayed: 1.36 -0.07 (4.9%)
Previous Close $1.43    52 Week High $ 
Open $1.43    52 Week Low $ 
Day High $1.51    P/E N/A 
Day Low $1.27    EPS $ 
Volume 153,233       

(NASDAQ: ALLR) Delayed: 1.36 -0.07 (4.9%)
Previous Close $1.43    52 Week High $ 
Open $1.43    52 Week Low $ 
Day High $1.51    P/E N/A 
Day Low $1.27    EPS $ 
Volume 153,233